Form 8-K - Current report:
SEC Accession No. 0001104659-20-051001
Filing Date
2020-04-24
Accepted
2020-04-24 16:18:05
Documents
1
Period of Report
2020-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016868-1_8k.htm 8-K 17135
  Complete submission text file 0001104659-20-051001.txt   18349
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 20815174
SIC: 2836 Biological Products, (No Diagnostic Substances)